Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Haidan Guo

Showing results (21-30 of 35) with videos related to

Pageof 4
Sort By:
Medrxiv : the Preprint Server for Health Sciences|September 25, 2023
Transcriptional Signatures of Hippocampal Tau Pathology in Primary Age-Related Tauopathy and Alzheimer's DiseaseGenevieve L Stein-O'Brien, Ryan Palaganas, Ernest M Meyer, et al.
Cell Reports|March 14, 2025
Transcriptional signatures of hippocampal tau pathology in primary age-related tauopathy and Alzheimer's diseaseGenevieve L Stein-O'Brien, Ryan Palaganas, Ernest M Meyer, et al.
Antimicrobial Agents and Chemotherapy|July 17, 2013
Pharmacokinetic and in vivo efficacy studies of the mycobactin biosynthesis inhibitor salicyl-AMS in miceShichun Lun, Haidan Guo, John Adamson, et al.
Journal of Medicinal Chemistry|April 25, 2013
Preliminary structure-activity relationships and biological evaluation of novel antitubercular indolecarboxamide derivatives against drug-susceptible and drug-resistant Mycobacterium tuberculosis strainsOluseye K Onajole, Marco Pieroni, Suresh K Tipparaju, et al.
The Journal of Antimicrobial Chemotherapy|November 5, 2011
Evaluation of gyrase B as a drug target in Mycobacterium tuberculosisSidharth Chopra, Karen Matsuyama, Tran Tran, et al.
Antimicrobial Agents and Chemotherapy|August 21, 2019
Revisiting the β-Lactams for Tuberculosis Therapy with a Compound-Compound Synthetic Lethality ApproachShiqi Xiao, Haidan Guo, Warren S Weiner, et al.
Plos One|April 28, 2010
The impact of mouse passaging of Mycobacterium tuberculosis strains prior to virulence testing in the mouse and guinea pig aerosol modelsPaul J Converse, Kathleen D Eisenach, Sue A Theus, et al.
Cancer Immunology Research|June 14, 2018
The Mutation-Associated Neoantigen Functional Expansion of Specific T Cells (MANAFEST) Assay: A Sensitive Platform for Monitoring Antitumor ImmunityLudmila Danilova, Valsamo Anagnostou, Justina X Caushi, et al.
Antimicrobial Agents and Chemotherapy|May 9, 2018
Impact of Clofazimine Dosing on Treatment Shortening of the First-Line Regimen in a Mouse Model of TuberculosisNicole C Ammerman, Rosemary V Swanson, Elaine M Bautista, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 23, 2019
Compartmental Analysis of T-cell Clonal Dynamics as a Function of Pathologic Response to Neoadjuvant PD-1 Blockade in Resectable Non-Small Cell Lung CancerJiajia Zhang, Zhicheng Ji, Justina X Caushi, et al.
Pageof 4

Showing results (21-30 of 35) with videos related to

Sort By:
Pageof 4
Medrxiv : the Preprint Server for Health Sciences|September 25, 2023
Transcriptional Signatures of Hippocampal Tau Pathology in Primary Age-Related Tauopathy and Alzheimer's DiseaseGenevieve L Stein-O'Brien, Ryan Palaganas, Ernest M Meyer, et al.
Cell Reports|March 14, 2025
Transcriptional signatures of hippocampal tau pathology in primary age-related tauopathy and Alzheimer's diseaseGenevieve L Stein-O'Brien, Ryan Palaganas, Ernest M Meyer, et al.
Antimicrobial Agents and Chemotherapy|July 17, 2013
Pharmacokinetic and in vivo efficacy studies of the mycobactin biosynthesis inhibitor salicyl-AMS in miceShichun Lun, Haidan Guo, John Adamson, et al.
Journal of Medicinal Chemistry|April 25, 2013
Preliminary structure-activity relationships and biological evaluation of novel antitubercular indolecarboxamide derivatives against drug-susceptible and drug-resistant Mycobacterium tuberculosis strainsOluseye K Onajole, Marco Pieroni, Suresh K Tipparaju, et al.
The Journal of Antimicrobial Chemotherapy|November 5, 2011
Evaluation of gyrase B as a drug target in Mycobacterium tuberculosisSidharth Chopra, Karen Matsuyama, Tran Tran, et al.
Antimicrobial Agents and Chemotherapy|August 21, 2019
Revisiting the β-Lactams for Tuberculosis Therapy with a Compound-Compound Synthetic Lethality ApproachShiqi Xiao, Haidan Guo, Warren S Weiner, et al.
Plos One|April 28, 2010
The impact of mouse passaging of Mycobacterium tuberculosis strains prior to virulence testing in the mouse and guinea pig aerosol modelsPaul J Converse, Kathleen D Eisenach, Sue A Theus, et al.
Cancer Immunology Research|June 14, 2018
The Mutation-Associated Neoantigen Functional Expansion of Specific T Cells (MANAFEST) Assay: A Sensitive Platform for Monitoring Antitumor ImmunityLudmila Danilova, Valsamo Anagnostou, Justina X Caushi, et al.
Antimicrobial Agents and Chemotherapy|May 9, 2018
Impact of Clofazimine Dosing on Treatment Shortening of the First-Line Regimen in a Mouse Model of TuberculosisNicole C Ammerman, Rosemary V Swanson, Elaine M Bautista, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 23, 2019
Compartmental Analysis of T-cell Clonal Dynamics as a Function of Pathologic Response to Neoadjuvant PD-1 Blockade in Resectable Non-Small Cell Lung CancerJiajia Zhang, Zhicheng Ji, Justina X Caushi, et al.
Pageof 4